Physician
Auerbach Hematology Oncology Associates P C
Auerbach Hematology Oncology Associates P C was paid $1.61M by Medicaid between May 2018 and Dec 2024, across 18 billing codes. Its largest line is Q0138, Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) — 62% of everything it billed.
33Billing provider infoAUERBACH HEMATOLOGY ONCOLOGY ASSOCIATES P C
BALTIMORE, MD 21237
BALTIMORE, MD 21237
33aNPI1710930391assigned 05/18/2006
33bProvider typeHematology & Oncology Physician
28Total paid$1.61M
24GClaims26,791
24DCodes billed18
24AFirst – last monthMay 2018 – Dec 2024
Compared with peers
Next to other Hematology & Oncology Physician providers in Maryland
Rank by total paid#3 of 30
Median peer was paid$116K
This provider vs. median14×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 112 | $1K | |
| 2019 | 355 | $1K | |
| 2020 | 3,207 | $190K | |
| 2021 | 5,730 | $363K | |
| 2022 | 7,142 | $348K | |
| 2023 | 6,465 | $494K | |
| 2024incomplete | 3,780 | $214K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 62% | 2,888 | 1,537 | $995K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 14% | 2,799 | 2,295 | $228K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 9.7% | 3,741 | 2,690 | $156K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 4.0% | 449 | 386 | $65K |
| 99244 | Office or other outpatient consultation, moderate to high complexity | 3.7% | 386 | 310 | $60K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.6% | 7,579 | 5,618 | $41K |
| J1750 | Injection, iron dextran, 50 mg | 1.3% | 105 | 87 | $21K |
| 36415 | Collection of venous blood by venipuncture | 1.1% | 7,893 | 5,711 | $18K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 1.1% | 305 | 255 | $17K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 60 | 24 | $5K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 290 | 190 | $3K |
| 96367 | <1% | 49 | 24 | $2K |
6 more codes
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 65 | $1K |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | <1% | 52 | $399.86 |
| 90674 | <1% | 14 | $329.34 | |
| J3490 | Unclassified drugs | <1% | 47 | $93.38 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 13 | $93.28 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 56 | $88.39 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialAUERBACH, MICHAEL (PRESIDENT)